{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T13:07:59Z","timestamp":1774098479273,"version":"3.50.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatriconcology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jgo.2025.102359","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:54:48Z","timestamp":1756482888000},"page":"102359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Interprofessional, risk-adapted medication management in older patients with cancer (IrMa)"],"prefix":"10.1016","volume":"16","author":[{"given":"Julia","family":"Thevissen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Therese","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yon-Dschun","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas H.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Jaehde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgo.2025.102359_bb0005","series-title":"Health workforce requirements for universal health coverage and the sustainable development goals","volume":"17","author":"World Health Organization (WHO)","year":"2016"},{"key":"10.1016\/j.jgo.2025.102359_bb0010","author":"Fachkr\u00e4ftemangel im deutschen Gesundheitswesen"},{"key":"10.1016\/j.jgo.2025.102359_bb0015","series-title":"Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. Krebs in Deutschland f\u00fcr 2019\/2020","author":"Robert-Koch-Institut","year":"2023"},{"key":"10.1016\/j.jgo.2025.102359_bb0020","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/s41571-020-0421-z","article-title":"Older adults with cancer and their caregivers - current landscape and future directions for clinical care","volume":"17","author":"Kadambi","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jgo.2025.102359_bb0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jgo.2015.12.002","article-title":"Comorbidity in older adults with cancer","volume":"7","author":"Williams","year":"2016","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2025.102359_bb0030","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.critrevonc.2006.11.001","article-title":"Comorbidity in patients with cancer: prevalence and severity measured by cumulative illness rating scale","volume":"61","author":"Wedding","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jgo.2025.102359_bb0035","first-page":"337","article-title":"The impact of comorbidity on cancer and its treatment","volume":"66","author":"Sarfati","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jgo.2025.102359_bb0040","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.6004\/jnccn.2021.0043","article-title":"NCCN guidelines\u00ae insights: older adult oncology, version 1.2021","volume":"19","author":"Dotan","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jgo.2025.102359_bb0045","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1200\/JCO.2013.54.8347","article-title":"International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer","volume":"32","author":"Wildiers","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2025.102359_bb0050","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jgo.2015.05.001","article-title":"Drug-related problems in elderly patients with cancer receiving outpatient chemotherapy","volume":"6","author":"Yeoh","year":"2015","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2025.102359_bb0055","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1634\/theoncologist.2019-0406","article-title":"Associations of polypharmacy and inappropriate medications with adverse outcomes in older adults with cancer: a systematic review and meta-analysis","volume":"25","author":"Mohamed","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.jgo.2025.102359_bb0060","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11912-018-0686-x","article-title":"Prevalence and risk of polypharmacy among elderly cancer patients receiving chemotherapy in ambulatory oncology setting","volume":"20","author":"Goh","year":"2018","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.jgo.2025.102359_bb0065","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/10781552241229662","article-title":"Drug-related problems in cancer patients: A systematic review","volume":"30","author":"Jayalakshmi","year":"2024","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.jgo.2025.102359_bb0070","first-page":"CD007768","article-title":"Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews","author":"Ryan","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgo.2025.102359_bb0075","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jgo.2017.04.005","article-title":"Implementing a pharmacist-led, individualized medication assessment and planning (iMAP) intervention to reduce medication related problems among older adults with cancer","volume":"8","author":"Nightingale","year":"2017","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2025.102359_bb0080","series-title":"Outcomes assessment of a pharmacist-directed seamless care program in an ambulatory oncology clinic","first-page":"46","volume":"27","author":"Edwards","year":"2014"},{"key":"10.1016\/j.jgo.2025.102359_bb0085","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1177\/10781552211066959","article-title":"The impact of medication reconciliation and review in patients using oral chemotherapy","volume":"29","author":"Darcis","year":"2023","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.jgo.2025.102359_bb0090","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2146\/ajhp160475","article-title":"Impact of clinical pharmacists in outpatient oncology practices: a review","volume":"74","author":"Gatwood","year":"2017","journal-title":"Am J Health-Syst Pharm"},{"key":"10.1016\/j.jgo.2025.102359_bb0095","series-title":"The impact of pharmacist-led strategies implemented to reduce errors related to cancer therapies: a systematic review","first-page":"466","volume":"50","author":"Coutsouvelis","year":"2020"},{"key":"10.1016\/j.jgo.2025.102359_bb0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jgo.2020.07.010","article-title":"Impact of a pharmacist and geriatrician medication review on drug-related problems in older outpatients with cancer","volume":"12","author":"Choukroun","year":"2021","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2025.102359_bb0105","first-page":"2669","article-title":"Pharmaceutical care for patients with breast and ovarian cancer","volume":"20","author":"Liekweg","year":"2012","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jgo.2025.102359_bb0110","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/502431","article-title":"Impact of clinical pharmacy services on KAP and QOL in cancer patients: a single-center experience","volume":"2015","author":"Wang","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jgo.2025.102359_bb0115","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/annonc\/mdr042","article-title":"Impact of a novel nurse-led prechemotherapy education intervention (ChemoEd) on patient distress, symptom burden, and treatment-related information and support needs: results from a randomised, controlled trial","volume":"23","author":"Aranda","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jgo.2025.102359_bb0120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11096-014-9915-z","article-title":"Influence of pharmaceutical care on the delayed emesis associated with chemotherapy","volume":"36","author":"Caracuel","year":"2014","journal-title":"Int J Clin Pharmacol"},{"key":"10.1016\/j.jgo.2025.102359_bb0125","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpainsymman.2006.11.018","article-title":"Symptom management for cancer patients: a trial comparing two multimodal interventions","volume":"34","author":"Sikorskii","year":"2007","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jgo.2025.102359_bb0130","first-page":"131","article-title":"Outcome of chemotherapy counseling by pharmacists on psychological effects and self esteem among oncology patients in a Government Hospital in Malaysia","volume":"70","author":"Ummavathy","year":"2015","journal-title":"Med J Malaysia"},{"key":"10.1016\/j.jgo.2025.102359_bb0135","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/jcpt.12562","article-title":"The effects of pharmacist interventions on adult outpatients with cancer: a systematic review","volume":"42","author":"Colombo","year":"2017","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.jgo.2025.102359_bb0140","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1053\/j.seminoncol.2003.12.027","article-title":"Chemotherapy in the elderly","volume":"31","author":"Lichtman","year":"2004","journal-title":"Semin Oncol"},{"issue":"19","key":"10.1016\/j.jgo.2025.102359_bb0145","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1200\/JCO.21.00089","article-title":"Geriatric assessment and management in cancer","volume":"39","author":"Rostoft","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2025.102359_bb0150","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/annonc\/mdu210","article-title":"Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations\u2020","volume":"26","author":"Decoster","year":"2015","journal-title":"Ann Oncol"},{"issue":"19","key":"10.1016\/j.jgo.2025.102359_bb0155","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1200\/JCO.21.00165","article-title":"Decision making in older adults with cancer","volume":"39","author":"DuMontier","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2025.102359_bb0160","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1002\/cncr.26646","article-title":"Predicting the risk of chemotherapy toxicity in older patients: the chemotherapy risk assessment scale for high-age patients (CRASH) score","volume":"118","author":"Extermann","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.jgo.2025.102359_bb0165","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1200\/JCO.2011.34.7625","article-title":"Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study","volume":"29","author":"Hurria","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2025.102359_bb0170","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jgo.2019.12.016","article-title":"Comparing the performance of the CARG and the CRASH score for predicting toxicity in older patients with cancer","volume":"11","author":"Ortland","year":"2020","journal-title":"J Geriatr Oncol"},{"issue":"19","key":"10.1016\/j.jgo.2025.102359_bb0175","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1200\/JCO.21.00195","article-title":"Understanding treatment tolerability in older adults with cancer","volume":"39","author":"Flannery","year":"2021","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.jgo.2025.102359_bb0180","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1200\/JCO.21.00118","article-title":"Models of care in geriatric oncology","volume":"39","author":"Chapman","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2025.102359_bb0185","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/OP.21.00198","article-title":"Predictive modeling for adverse events and risk stratification programs for people receiving cancer treatment","volume":"18","author":"Osterman","year":"2022","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.jgo.2025.102359_bb0190","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1177\/1078155220962178","article-title":"Drug-related problems in head and neck cancer patients identified by repeated medication reviews on consecutive therapy cycles","volume":"27","author":"Vucur","year":"2021","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.jgo.2025.102359_bb0195","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1186\/s12877-022-03390-z","article-title":"Medication risks in older patients (70 +) with cancer and their association with therapy-related toxicity","volume":"22","author":"Ortland","year":"2022","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jgo.2025.102359_bb0200","author":"ABDA \u2013 Bundesvereinigung Deutscher Apothekerverb\u00e4nde e. V"},{"key":"10.1016\/j.jgo.2025.102359_bb0205","author":"Multinational Association of Supportive Care in Cancer (MASCC)"},{"key":"10.1016\/j.jgo.2025.102359_bb0210","author":"AVOXA\/ABDATA"},{"key":"10.1016\/j.jgo.2025.102359_bb0215","author":"Universit\u00e4tsklinkum Heidelberg"},{"key":"10.1016\/j.jgo.2025.102359_bb0220","first-page":"543","article-title":"Potentially inappropriate medications in the elderly: the PRISCUS list","volume":"107","author":"Holt","year":"2010","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.jgo.2025.102359_bb0225","author":"Pazan"},{"key":"10.1016\/j.jgo.2025.102359_bb0230","author":"Pharmaceutical Care Network Europe (PCNE)"},{"key":"10.1016\/j.jgo.2025.102359_bb0235","author":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V. (AWMF)"},{"key":"10.1016\/j.jgo.2025.102359_bb0240","series-title":"Qualitative Inhaltsanalyse: Grundlagen und Techniken","author":"Mayring","year":"2010"},{"key":"10.1016\/j.jgo.2025.102359_bb0245","series-title":"Qualitative Inhaltsanalyse. Methoden, Praxis, Computerunterst\u00fctzung: Grundlagentexte Methoden","author":"Kuckartz","year":"2022"},{"key":"10.1016\/j.jgo.2025.102359_bb0250","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0 (v5.0: November 27, 2017) U.S. Department of Health and Human Service National Institutes of Health. http:\/\/evs.nci.nih.gov. Accessed 18 April 2025."},{"key":"10.1016\/j.jgo.2025.102359_bb0255","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju129","article-title":"Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials","volume":"106","author":"Reeve","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jgo.2025.102359_bb0260","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1093\/annonc\/mdw422","article-title":"Validation of the German patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE\u2122)","volume":"27","author":"Hagelstein","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jgo.2025.102359_bb0265","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/1740774520975120","article-title":"Composite grading algorithm for the National Cancer Institute\u2019s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)","volume":"18","author":"Basch","year":"2021","journal-title":"Clin Trials"},{"key":"10.1016\/j.jgo.2025.102359_bb0270","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.clinthera.2016.03.011","article-title":"Methods for implementing and reporting patient-reported outcome (PRO) measures of symptomatic adverse events in cancer clinical trials","volume":"38","author":"Basch","year":"2016","journal-title":"Clin Ther"},{"key":"10.1016\/j.jgo.2025.102359_bb0275","series-title":"EuroQol - a new facility for the measurement of health-related quality of life. Health Policy","volume":"16","author":"The EuroQol Group","year":"1990"},{"key":"10.1016\/j.jgo.2025.102359_bb0280","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s40273-018-0615-8","article-title":"German value set for the EQ-5D-5L","volume":"36","author":"Ludwig","year":"2018","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jgo.2025.102359_bb0285","author":"EuroQol Research Foundation"},{"key":"10.1016\/j.jgo.2025.102359_bb0290","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/sim.4780091208","article-title":"Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk","volume":"9","author":"Farrington","year":"1990","journal-title":"Stat Med"},{"key":"10.1016\/j.jgo.2025.102359_bb0295","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MLR.0000000000001664","article-title":"Guidelines for designing and evaluating feasibility pilot studies","volume":"60","author":"Teresi","year":"2022","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.jgo.2025.102359_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-10-1","article-title":"A tutorial on pilot studies: the what, why and how","volume":"10","author":"Thabane","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jgo.2025.102359_bb0305","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jgo.2018.03.014","article-title":"The effect of a geriatric evaluation on treatment decisions and outcome for older cancer patients - A systematic review","volume":"9","author":"Hamaker","year":"2018","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jgo.2025.102359_bb0310","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12877-020-01625-5","article-title":"Implementing a multidisciplinary approach for older adults with cancer: geriatric oncology in practice","volume":"20","author":"Presley","year":"2020","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jgo.2025.102359_bb0315","first-page":"605","article-title":"Geriatric assessment with management intervention in older adults with cancer: a randomized pilot study","volume":"26","author":"Magnuson","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jgo.2025.102359_bb0320","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(21)01789-X","article-title":"Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study","volume":"398","author":"Mohile","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jgo.2025.102359_bb0325","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/bjc.2015.120","article-title":"The impact of comprehensive geriatric assessment interventions on tolerance to chemotherapy in older people","volume":"112","author":"Kalsi","year":"2015","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.jgo.2025.102359_bb0330","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1200\/JCO.22.00738","article-title":"Effects of a geriatric assessment intervention on patient-reported symptomatic toxicity in older adults with advanced cancer","volume":"41","author":"Culakova","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2025.102359_bb0335","doi-asserted-by":"crossref","first-page":"6191","DOI":"10.1200\/JCO.2008.20.6755","article-title":"Effectiveness of a home care nursing program in the symptom management of patients with colorectal and breast cancer receiving oral chemotherapy: a randomized, controlled trial","volume":"27","author":"Molassiotis","year":"2009","journal-title":"JCO"},{"key":"10.1016\/j.jgo.2025.102359_bb0340","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejphar.2013.09.071","article-title":"Anticipatory nausea and vomiting due to chemotherapy","volume":"722","author":"Kamen","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jgo.2025.102359_bb0345","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.4158","article-title":"Geriatric assessment-driven intervention (GAIN) on chemotherapy-related toxic effects in older adults with cancer: a randomized clinical trial","volume":"7","author":"Li","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jgo.2025.102359_bb0350","first-page":"109","article-title":"A randomized phase II trial of geriatric assessment and management for older cancer patients","volume":"26","author":"Puts","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jgo.2025.102359_bb0355","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/s41416-021-01367-0","article-title":"The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO)","volume":"124","author":"Lund","year":"2021","journal-title":"Br J Cancer"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406825001754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406825001754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:52:15Z","timestamp":1765975935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406825001754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":71,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1879406825001754"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2025.102359","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interprofessional, risk-adapted medication management in older patients with cancer (IrMa)","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2025.102359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102359"}}